Research
Aeolus Pharmaceuticals, Inc., published additional data demonstrating the efficacy of AEOL 10150 as a medical countermeasure to sulfur mustard gas exposure on Monday.
The data showed that treatment with AEOL 10150 48 hours after exposure to sulfur mustard gas improved survival rates from 36... Read More »
New York’s proposed cyber security regulations for banks and insurance companies - the first such policy in the nation - would create some uniformity between state and federal rules, but the American Bankers Association (ABA) said that it is seeking clarification on certain provisions.
“We... Read More »
Elusys Therapeutics, Inc., published data on Thursday on more than 450 healthy adult subjects from five clinical trials used to support recent U.S. Food and Drug Administration (FDA) marketing approval of ANTHIM injection.
ANTHIM is used in adult and pediatric patients for the treatment of... Read More »
The National Institutes of Health (NIH) recently released plans to hold a contest to develop new, innovative laboratory diagnostic tools that detect antibiotic-resistant bacteria.
The contest, called the Antimicrobial Resistance Diagnostic Challenge, will award prizes totaling $20 million over... Read More »
Aeolus Pharmaceuticals, Inc., recently released data confirming the efficacy of AEOL 10150 as a medical countermeasure against sulfur mustard gas inhalation.
Research for the study was conducted by Dr. Brian Day, vice chair of research at National Jewish Health, in collaboration with the U.S.... Read More »
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently provided Takeda Vaccines, Inc., with a grant to develop a Zika virus vaccine.
The grant, worth $19.8 million, will be spaced out over the course of the next 18... Read More »
The U.S. government has become “somewhat complacent” in preparing for potential bioterrorist attacks and needs to implement a national biodefense strategy, Daniel Gerstein, a senior policy researcher at the nonpartisan RAND Corporation, recently told Homeland Preparedness News.
The anthrax... Read More »
A collaborative research effort by the Johns Hopkins University School of Medicine, the National Institutes of Health and Florida State University recently revealed two classes of compounds already in use in the pharmaceutical industry that might prove useful in the fight against Zika virus.... Read More »
Researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID) recently developed a novel system to grow norovirus in intestinal cells, which could bring about new therapeutic drugs and vaccines to combat the virus.
Intestinal cells are the natural site of norovirus... Read More »
The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Chembio Diagnostic Systems, Inc., a $5.9 million contract on Wednesday for the development of a Zika virus test for use in doctors’ offices.
Chembio is... Read More »
Johns Hopkins Medicine formally opened the Johns Hopkins Wilmer Zika Center on Tuesday, becoming the first known multidisciplinary Zika virus center in the world.
The center is composed of providers and related staff from departments and divisions at Johns Hopkins Medicine and the Johns Hopkins... Read More »
The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) entered into a $2.6 million agreement on Monday with the DiaSorin Group to further the development of a Zika virus test that may help diagnose the virus more quickly.... Read More »
Researchers at the University of Texas Medical Branch (UTMB) released a study on Monday showing the successful treatment of monkeys infected with Sudan ebolavirus (SUDV) several days after infection.
Scientists have known about SUDV and Zaire ebolavirus (EBOV) since 1976, with EBOV being the... Read More »
The U.S. Food and Drug Administration (FDA) recently approved Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) for the manufacture of BioThrax (Anthrax Vaccine Adsorbed) at the company’s large-scale Building 55 manufacturing facility in Lansing,... Read More »
ClinicalRM recently expanded access protocol with ZMapp, an investigational treatment for Ebola virus disease (EVD) in Africa and the United States.
ZMapp combines three monoclonal antibodies developed by Mapp Biopharmaceutical, Inc., and LeafBio, the commercialization arm of Mapp, to fight... Read More »
Hologic, Inc., entered into an agreement on Tuesday worth $4.1 million with the U.S. Department of Health and Human Services’ (HHS) Office of the Assistance Secretary for Preparedness and Response (ASPR) to advance the development of a blood screening test that will detect Zika virus.
The one... Read More »
A major gap in international standards for biosafety in laboratories handling contagious pathogens potentially increases the risk that an accident could result in a disease outbreak that threatens global security, according to a recent study by the UPMC Center for Health Security.
The year-long... Read More »
A team of researchers at the Lawrence Livermore National Laboratory (LLNL) recently developed a flexible material that is both highly breathable and protective from various biological agents that soldiers may come into contact with.
The material is the first key component of a new type of... Read More »
Deep Red, Raytheon Company’s team of cyber experts, is one of the featured teams competing in the Defense Advance Research Projects Agency (DARPA) Cyber Grand Challenge finals during the DEF CON conference this week.
DARPA began the Cyber Grand Challenge as a computer security tournament... Read More »
Altimmune, Inc., and the Biomedical Advanced Research and Development Authority (BARDA) are set to advance the first clinical trial later this month of an anthrax vaccine that could be administered in a single dose.
The trial was initiated from a two-year, $14 million contract between BARDA and... Read More »
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $5.1 million, two-year contract to InBios International, Inc., on Monday for a newer, faster Zika virus diagnostic blood test.
InBios’ test may have the... Read More »
The National Institutes of Health (NIH) launched a clinical trial this week for an experimental vaccine to prevent Zika virus infections, an effort that comes after local transmission of the virus hit a neighborhood in Florida.
“Given the Zika situation internationally and in the United... Read More »
The Defense Advanced Research Projects Agency (DARPA) will host the world’s first all-machine hacking tournament this week.
The Cyber Grand Challenge marks the culmination of an ambitious three-year effort to develop advanced, autonomous systems that can detect, evaluate and patch software... Read More »
U.S. Sen. Marco Rubio (R-FL) on Wednesday urged President Obama to use unspent funds from other programs to combat the emerging threat of Zika virus in the United States.
Rubio sent a letter to the president, citing specific examples of unused funds that could be reallocated in an expedited... Read More »
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), released a study on Wednesday that found six Zika virus antibodies, including four that neutralize African, Asian and American strains of the virus.
Dr. Michael S.... Read More »
U.S. Rep. Dan Donovan (R-NY) on Tuesday decried actions by his congressional colleagues for jeopardizing the development of a vaccine for the Zika virus.
Donovan’s statement came in the wake of three different companies threatening to halt their developments due to funding uncertainty.... Read More »
Soligenix released positive preliminary proof-of-concept results on Monday from its collaboration with Axel Lehrer to develop a heat-stable subunit Ebola virus vaccine.
Lehrer is a doctor in the Department of Medicine, Medical Microbiology and Pharmacology at the John A. Burns School of... Read More »
Researchers at the Edgewood Chemical Biological Center (ECBC) and CBI Polymer recently explored how a HydroGel can be modified to decontaminate surfaces contaminated with harmful biological agents, such as the anthrax-inducing Bacillus anthracis.
HydroGel is a biosynthetic polymer that can be... Read More »
The U.S. Food and Drug Administration (FDA) began a series of actions this week designed to combat the emerging threat of Zika virus and to mitigate its spread throughout the U.S. and the world.
The FDA began with important steps to help protect the safety of the blood supply. One of the first... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) provided BioCryst Pharmaceuticals with additional funding on Monday for efficacy studies of BCX4430 in non-human primates to further assist effective dose regimens.
BCX4430 is a broad-spectrum antiviral that is advancing toward... Read More »
An independent panel of public health, emergency response and communication experts issued a report on Friday on the Ebola epidemic of 2014, identifying recommendations to improve the U.S. Department of Health and Human Services (HHS) response to urgent public health threats.
Concerns... Read More »
The Partnership for Research on Ebola virus in Liberia (PREVAIL) on Monday opened PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material - RNA - in their semen.
The trial is sponsored by the National... Read More »
A coalition of research institutions published a report in the Clinical Infectious Disease Journal on Wednesday that analyzed the immune responses of Ebola patients treated in the United States.
The coalition includes the U.S. Centers for Disease and Control (CDC), the Emory University School... Read More »
The National Institutes of Allergy and Infectious Diseases (NIAID) released a report on Tuesday detailing how a single dose of either of two experimental Zika vaccines protected mice infected with the virus for four to eight weeks after receiving the inoculations.
NIAID said that this... Read More »
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) presented data on Monday regarding gene sequences and the global variations in malaria parasites.
NIAID researchers determined the genomes of approximately 200 P. vivax strains that recently infected people in... Read More »
